Timothy Mitchell
Founder en SAREUM HOLDINGS PLC .
Fortuna: 140 222 $ al 31/03/2024
Perfil
Timothy John Mitchell was the founder of Sareum Holdings Plc, where he held the title of Chief Executive Officer & Executive Director until his departure.
Sareum Holdings Plc was founded in 2003.
Dr. Mitchell's former positions include Director-Computational Chemistry at Cambridge Discovery Chemistry and Director-Structure Based Discovery at Millennium Pharmaceuticals Research & Development Ltd.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SAREUM HOLDINGS PLC
1.44% | 28/03/2024 | 1 032 561 ( 1.44% ) | 140 222 $ | 31/03/2024 |
Cargos activos de Timothy Mitchell
Empresas | Cargo | Inicio |
---|---|---|
SAREUM HOLDINGS PLC | Founder | 01/08/2003 |
Antiguos cargos conocidos de Timothy Mitchell.
Empresas | Cargo | Fin |
---|---|---|
Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SAREUM HOLDINGS PLC | Miscellaneous |
Empresas privadas | 2 |
---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
Millennium Pharmaceuticals Research & Development Ltd. |
- Bolsa de valores
- Insiders
- Timothy Mitchell